Weight loss outcomes with semaglutide based on diabetes severity ...

Our search demonstrated that semaglutide led to inferior weight loss outcomes in patients with diabetes compared to patients without diabetes in ...

We aim to assess weight loss outcomes of semaglutide based on IMS score in patients with obesity and T2D.

Semaglutide weight loss results linked to diabetes severity

Researchers theorized that patients with severe T2D, as indicated by higher IMS scores, would experience less weight loss with semaglutide ...

Weight Loss Outcomes Associated With Semaglutide Treatment for ...

Patients with type 2 diabetes had a lower mean (SD) percentage weight loss at 3 and 6 months compared with those without type 2 diabetes: 3.9% ( ...

WEIGHT LOSS OUTCOMES WITH SEMAGLUTIDE BASED ON ...

Primary outcomes were percent total body weight loss (%TBWL) 12 and 24 months after treatment initiation. The secondary outcome was change in hepatic steatosis ...

Weight Loss Outcomes Associated With Semaglutide Treatment for ...

Patients with type 2 diabetes had a lower mean (SD) percentage weight loss at 3 and 6 months compared with those without type 2 diabetes: 3.9% ( ...

Association between individualized metabolic surgery scores and ...

Our data suggest that patients with less severe diabetes may experience more substantial weight-loss benefits from semaglutide." — Andres J.

Long-term weight loss effects of semaglutide in obesity without ...

In STEP 1, a large phase 3 study of once-weekly subcutaneous semaglutide 2.4 mg in individuals without diabetes but with BMI >30 kg m−2 or 27 kg ...

Weight loss outcomes with semaglutide based on diabetes severity ...

Background: Semaglutide demonstrated inferior weight loss responses in patients with type 2 diabetes (T2D) compared to patients with obesity without T2D.

(PDF) Weight loss outcomes with semaglutide based on diabetes ...

Background Semaglutide demonstrated inferior weight loss responses in patients with type 2 diabetes (T2D) compared to patients with obesity ...

Two-year effects of semaglutide in adults with overweight or obesity

In the STEP 1 and 3 trials in participants without type 2 diabetes, average placebo-subtracted weight losses of 12.4% and 10.3%, respectively, ...

eClinicalMedicine – The Lancet Discovery Science - X.com

Weight loss outcomes with #semaglutide based on #diabetes severity using the individualized metabolic surgery (IMS) score Lower IMS severity ...

Efficacy and safety of semaglutide 2.4 mg for weight loss in ...

In overweight or obese non-diabetic individuals, semaglutide had a remarkable and sustained weight loss effect that was well tolerated and safe.

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Semaglutide induced weight loss in persons with type 2 diabetes and in adults with obesity who were participants in a phase 2 trial, findings ...

Novel Score Predicts Weight Loss With Semaglutide in T2D

The primary endpoint was weight loss outcomes based on four IMS score quartiles (quartile 1, 12-78 points; quartile 2, 79-107 points; quartile 3 ...

Weight loss outcomes, tolerability, side effects, and risks

In clinical trials, liraglutide showed a placebo-corrected weight loss of around 5 %, semaglutide 12 %, and tirzepatide 18 %. Common side effects were ...

Semaglutide vs Tirzepatide for Weight Loss in Adults With ...

Findings In this cohort study of 18 386 propensity-score matched patients initiating tirzepatide or semaglutide labeled for type 2 diabetes, ...

Semaglutide 2.4 mg/wk for weight loss in patients with severe ...

Results. Semaglutide treatment resulted in significant 9.1% weight loss in the BS+ group, with no significant difference in weight loss between ...

Semaglutide for Weight Loss in Patients With Severe Obesity With or ...

Semaglutide treatment resulted in a weight loss of 9.8% in the BS+ group and a weight loss of 8.7% in the BS− group. The study suggests that ...

702 WEIGHT LOSS OUTCOMES WITH SEMAGLUTIDE BASED ON ...

Background Semaglutide demonstrated inferior weight loss responses in patients with type 2 diabetes (T2D) compared to patients with obesity without T2D.